Bacterial infections of the lung in normal and immunodeficient patients

David P Speert1

  • 1Room 377, Child and Family Research Institute, 950 West 28th Avenue, Vancouver BC, Canada, V5Z 4H4.

Novartis Foundation Symposium
|February 7, 2007
PubMed

Insights

The lungs possess remarkable natural defenses against airborne pathogens. However, in individuals with weakened immune systems, a wider range of bacteria can cause severe lung infections, indicating an underlying immunocompromising condition.

Area of Science:

  • Immunology
  • Pulmonology
  • Microbiology

Background:

  • The respiratory tract possesses robust natural defenses against inhaled pathogens.
  • Common bacterial lung infections in healthy individuals are typically caused by specific pathogens like Streptococcus pneumoniae.
  • In immunocompromised hosts, a broader spectrum of bacteria, including less virulent species, can cause pneumonia.

Purpose of the Study:

  • To highlight the critical role of the immune system in preventing bacterial lung infections.
  • To underscore the importance of investigating immunocompromising conditions when unusual bacterial lung pathogens are identified.
  • To detail the multifaceted defense mechanisms of the respiratory tract.

Main Methods:

  • Review of established knowledge on respiratory tract defenses.
  • Analysis of common and opportunistic bacterial pathogens causing lung infections.
  • Examination of various immunocompromising conditions affecting lung immunity.

Main Results:

  • Respiratory defenses include physical barriers (mucociliary escalator) and innate factors (defensins, lysozyme, phagocytes).
  • Adaptive immunity, enhanced by opsonins (surfactant, complement, immunoglobulins), further protects against bacterial invasion.
  • Immunocompromising conditions such as hypogammaglobulinaemia, chronic granulomatous disease, and primary ciliary dyskinesia predispose individuals to severe bacterial pneumonia.

Conclusions:

  • The integrity of both innate and adaptive immune systems is essential for maintaining a sterile lower respiratory tract.
  • Identifying unusual bacterial lung pathogens necessitates a thorough search for underlying immunocompromising conditions.
  • Understanding these defense mechanisms and vulnerabilities is crucial for managing and preventing lung infections.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: